Showing 1 posts of 1 posts found.


Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Latest content